Literature DB >> 15253448

Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-Ms/MS using protein cleavage and isotope dilution mass spectrometry.

David R Barnidge1, Marcia K Goodmanson, George G Klee, David C Muddiman.   

Abstract

Protein cleavage-isotope dilution mass spectrometry (PC-IDMS) can be used to quantify proteins, with an isotope-labeled analogue of the peptide fragment used as an internal standard. Here, we investigate use of a standard LC-MS/MS platform for quantifying a model biomarker directly from serum by this technique. We synthesized a peptide (IVGGWECEK) identical to the N-terminal tryptic fragment of PSA but with each glycine containing two 13C atoms and one 15N atom. PSA-free human serum was denatured with urea followed by the introduction of PSA standard and the stable isotope labeled internal standard peptide. The sample was then proteolyzed with trypsin and subjected to quantification using LC-MS/ MS on a triple quadrupole mass spectrometer. A linear least squares calibration curve made from five different concentrations of PSA added to serum and digested (each made in triplicate and randomly injected three times) had a mean slope of 0.973 (SE = 0.023), intercept of -0.003 (SE = 0.022), and R2 of 0.971. Recovery of calibrators ranged from 70 to 85% with a mean run-to-run CV of 13% and a mean within-run CV of 5.7%. PC-IDMS is a promising technique for quantifying proteins covering a broad range of applications from standardizing immunoassays to monitoring post-translational modifications to quantifying newly discovered biomarkers prior to the development and implementation of an immunoassay, just to name a few. Issues surrounding the application of PC-IDMS for the absolute quantification of proteins include selection of a proteolytic fragment for quantification that can be cleaved and isolated reproducibly over a broad dynamic range, stable isotope labeled synthetic peptide standards that give consistent results, and LC-MS/MS methods that provide adequate sensitivity and reproducibility without creating impractical analysis times. The results presented here show that absolute quantification can be performed on the model biomarker PSA introduced into denatured serum when analyzed by LC-MS/MS. However, concerns still exist regarding sensitivity compared to existing immunoassays as well as the reproducibility of PC-IDMS performed in different matrixes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15253448     DOI: 10.1021/pr049963d

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  70 in total

1.  The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.

Authors:  Amanda G Paulovich; Jeffrey R Whiteaker; Andrew N Hoofnagle; Pei Wang
Journal:  Proteomics Clin Appl       Date:  2008-10-01       Impact factor: 3.494

2.  Mass spectrometry-based detection and quantification of plasma glycoproteins using selective reaction monitoring.

Authors:  Yeoun Jin Kim; Zaya Zaidi-Ainouch; Sebastien Gallien; Bruno Domon
Journal:  Nat Protoc       Date:  2012-04-12       Impact factor: 13.491

3.  Absolute quantitation of isoforms of post-translationally modified proteins in transgenic organism.

Authors:  Yaojun Li; Yiwei Shu; Changchao Peng; Lin Zhu; Guangyu Guo; Ning Li
Journal:  Mol Cell Proteomics       Date:  2012-03-22       Impact factor: 5.911

4.  A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin.

Authors:  Jennifer L Proc; Michael A Kuzyk; Darryl B Hardie; Juncong Yang; Derek S Smith; Angela M Jackson; Carol E Parker; Christoph H Borchers
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

5.  Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma.

Authors:  Adam M Hawkridge; Rebecca B Wysocky; James N Petitte; Kenneth E Anderson; Paul E Mozdziak; Oscar J Fletcher; Jonathan M Horowitz; David C Muddiman
Journal:  Anal Bioanal Chem       Date:  2010-07-17       Impact factor: 4.142

6.  Establishing ion ratio thresholds based on absolute peak area for absolute protein quantification using protein cleavage isotope dilution mass spectrometry.

Authors:  Philip L Loziuk; Ronald R Sederoff; Vincent L Chiang; David C Muddiman
Journal:  Analyst       Date:  2014-11-07       Impact factor: 4.616

7.  Measurement of human surfactant protein-B turnover in vivo from tracheal aspirates using targeted proteomics.

Authors:  Daniela M Tomazela; Bruce W Patterson; Elizabeth Hanson; Kimberly L Spence; Tiffany B Kanion; David H Salinger; Paolo Vicini; Hugh Barret; Hillary B Heins; F Sessions Cole; Aaron Hamvas; Michael J MacCoss
Journal:  Anal Chem       Date:  2010-03-15       Impact factor: 6.986

8.  Mapping sites of protein phosphorylation by mass spectrometry utilizing a chemical-enzymatic approach: characterization of products from alpha-S1 casein phosphopeptides.

Authors:  Daniel J McCormick; Michael W Holmes; David C Muddiman; Benjamin J Madden
Journal:  J Proteome Res       Date:  2005 Mar-Apr       Impact factor: 4.466

9.  Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers.

Authors:  Jeffrey R Whiteaker; Lei Zhao; Heidi Y Zhang; Li-Chia Feng; Brian D Piening; Leigh Anderson; Amanda G Paulovich
Journal:  Anal Biochem       Date:  2006-12-20       Impact factor: 3.365

10.  Immunoglobulins: expanding the role for mass spectrometry in protein biomarker quantification.

Authors:  John M Koomen
Journal:  Clin Chem       Date:  2014-06-17       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.